Eckhard R. Podack,Taylor H. Schreiber,Samia Q. Khan
申请号：
US14151497
公开号：
US20140193410A1
申请日:
2014.01.09
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Compositions comprising TL1A-Ig fusion proteins and methods of their use, e.g., for the treatment of diseases and disorders associated with antigen-specific immune responses, are described. Also described are combination therapies that include the administration of a TNFRSF25 agonist and an interleukin (e.g., IL-2) and/or an mTOR inhibitor (e.g., rapamycin).
